Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C Synergy with TKI in EGFR-Mutated Lung Adenocarcinoma
NCT03799094Phase 2Unknown
- Sponsor
- Clifford Hospital
- Start
- Dec 2018
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in lung adenocarcinoma (LUAD), sponsored by Clifford Hospital. Status: unknown.
02
Drugs
ascorbic acid
03
Conditions
lung adenocarcinoma (LUAD)
Beyond the preview
Go deeper on NCT03799094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03799094.